Duodenal–jejunal bypass liner
Last revised by Daniel J Bell on 4 Jun 2019
Citation, DOI, disclosures and article data
Citation:
Bell D, Duodenal–jejunal bypass liner. Reference article, Radiopaedia.org (Accessed on 25 Apr 2024) https://doi.org/10.53347/rID-68509
rID:
68509
Article created:
3 Jun 2019,
Daniel J Bell ◉
Disclosures:
At the time the article was created Daniel J Bell had no recorded disclosures.
View Daniel J Bell's current disclosures
Last revised:
4 Jun 2019,
Daniel J Bell ◉
Disclosures:
At the time the article was last revised Daniel J Bell had no recorded disclosures.
View Daniel J Bell's current disclosures
Revisions:
1 time, by
1 contributor -
see full revision history and disclosures
Systems:
Synonyms:
- Endobarrier
- Duodenal-jejunal bypass sleeve device
- Endobarriers
- Duodenal-jejunal bypass sleeve devices
- Duodenal–jejunal bypass liner (DJBL)
- Duodenal–jejunal bypass liners
- Duodenal-jejunal bypass sleeve (DJBS)
A duodenal–jejunal bypass liner (DJBL), also known as a duodenal–jejunal bypass sleeve device or EndoBarrier™ is being trialled as a new technique, as an alternative to more 'traditional' gastric bypass surgeries 1,2. The basic principle is that the sleeve is endoscopically-inserted into the duodenum with an impervious liner preventing absorption of the chyme by the duodenum or the proximal jejunum.
References
- 1. Tripolt NJ, Aberer F, Url J, Högenauer C, Schreiber F, Eherer A, Sourij C, Obermayer AM, Stadlbauer V, Svehlikova E, Brunner M, Kojzar H, Pferschy PN, Pieber TR, Sourij H. Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial. (2019) Diabetes therapy : research, treatment and education of diabetes and related disorders. 10 (1): 299-309. doi:10.1007/s13300-018-0540-z - Pubmed
- 2. Glaysher MA, Mohanaruban A, Prechtl CG, Goldstone AP, Miras AD, Lord J, Chhina N, Falaschetti E, Johnson NA, Al-Najim W, Smith C, Li JV, Patel M, Ahmed AR, Moore M, Poulter N, Bloom S, Darzi A, Le Roux C, Byrne JP, Teare JP. A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. (2017) BMJ open. 7 (11): e018598. doi:10.1136/bmjopen-2017-018598 - Pubmed